Ficacy of PDT-induced anti-tumor immunity relies both on innate and humoral immunity, and is a AZD3759 site significant determinant of the overall outcome following photofrin-PDT [175]. Finally, BPD-PDT of poorly immunogenic mouse sarcomas (RIF1) in immunocompetent C3H/HeN mice led to the disappearance of tumors followed by an eventual recurrence. The authors then transfected the RIF-1 …
Continue reading “Ficacy of PDT-induced anti-tumor immunity relies both on innate and humoral”